ACADIA Pharmaceuticals
ACAD
#3220
Rank
ยฃ3.40 B
Marketcap
ยฃ20.15
Share price
-2.20%
Change (1 day)
36.95%
Change (1 year)

ACADIA Pharmaceuticals (ACAD) - Cash on Hand

Cash on Hand as of September 2025 : ยฃ0.63 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company has ยฃ0.63 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

ACADIA Pharmaceuticals - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31ยฃ0.60 B74.88%
2023-12-31ยฃ0.34 B-0.02%
2022-12-31ยฃ0.34 B-10.68%
2021-12-31ยฃ0.38 B-16.8%
2020-12-31ยฃ0.46 B-12.83%
2019-12-31ยฃ0.53 B42.57%
2018-12-31ยฃ0.37 B47.7%
2017-12-31ยฃ0.25 B-41.09%
2016-12-31ยฃ0.42 B195.34%
2015-12-31ยฃ0.14 B-29.91%
2014-12-31ยฃ0.20 B83.9%
2013-12-31ยฃ0.11 B68.61%
2012-12-31ยฃ66.79 M234.4%
2011-12-31ยฃ19.97 M-16.85%
2010-12-31ยฃ24.02 M-17.39%
2009-12-31ยฃ29.08 M-29.06%
2008-12-31ยฃ40.99 M-35.8%
2007-12-31ยฃ63.85 M50.24%
2006-12-31ยฃ42.5 M70.45%
2005-12-31ยฃ24.93 M33.24%
2004-12-31ยฃ18.71 M23.01%
2003-12-31ยฃ15.21 M96.1%
2002-12-31ยฃ7.75 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Vanda Pharmaceuticals
VNDA
ยฃ0.22 B-65.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ11.25 B 1,669.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ7.44 B 1,070.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
ยฃ13.93 B 2,091.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ12.39 B 1,848.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Adamas Pharmaceuticals
ADMS
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA